INTRODUCTION
Since its introduction in the early 1980s (1] ) percutaneous endoscopic gastrostomy (PEG) has become the modality of choice for providing longterm enteral nutrition in patients with inadequate oral intake. It has now replaced surgical gastrostomy, which was associated with a markedly higher rate of complications (2) . Several studies have clearly shown the advantages of PEG tube over nasogastric tube feeding in medium-and long-term enteral feeding. Feeding via nasogastric tubes was found to have higher rate of complications and discomfort as well as a lower nutritional efficacy when compared with nutrition via PEG tubes. PEG-feeding, therefore, has rapidly spread and over the last three decades expanded the range of indications (3, 4) .
This study aimed to review and evaluate indications and complications associated with PEG tube placement in a single, tertiary care University Hospital over a seven-year period.
MATERIALS AND METHODS
We conducted a retrospective review of PEG tube placement in our institution, the Medical Center University of Sarajevo, performed between January 2005 and October 2012. Corresponding patient medical records were reviewed to assess primary diagnosis and complications occurring during PEG tube placement as well as complications associated with PEG use. The patient charts included patient demographics, follow-up information and outcome. Additional follow-up information was also obtained by direct telephone contact with the referring doctor, family or nursing personnel.
The PEG placement was performed using the pull technique described by Ponsky and Gauderer (1) . No routine antibiotic prophylaxis before PEG placement was used.
RESULTS
Between January 2005 and October 2012 a total of 366 PEG procedures were performed of which 359 tubes were successfully inserted. In 7 patients PEG insertion failed due to anatomical anomaly or malignant GI obstruction, these patients were excluded from the study. 48 patients were children, in the age between 3 months and 14 years, mean age 5.7 years with 67% being male. The mean age of the adult patient cohort (n=311) was 65.7 years (range 19 to 84 years) with 63% being female. The number of PEG tube placements annually has increased from 37 in 2005 to 63 in 2011, which was indications, technical success, complications and the need for repeat procedures. Results: the indications for enteral feeding tube placement were malignancy in 44% (n=158), of which 61% (n=97) patients were suffering of head and neck cancer and 39% (n=61) of other malignancy. Central nervous disease was the indication in 48.7 % (n=175) of patients. Cerebrovascular accidents (CVa) accounted for 20% (n=73), head injury for 16% (n=59) and cerebral palsy for 11% (n=38). in 6.13% (n=22) of patients minor complications occur which included wound infection (0.8%), inadvertent PEG removal (2.5%) and tube blockage (1.1%). 11 patients experienced major complications including hemorrhage, tube migration and perforation. there were no deaths related to PEG procedure placement and the overall 30-day mortality rate due to primary disease was 15.8%. oral feeding was resumed in 23% of the patients and the tube was removed subsequently after 6 -12 months. Conclusions: Percutaneous endoscopic gastrostomy is a save and minimally invasive endoscopic procedure associated with a low morbidity (9.2%) rate, easy to follow-up and to replace when blockage occurs. over a seven-year period we noticed an increase of 63% in PEG placement at our department. Key words: PEG, enteral nutrition, tube feeding.
accompanied by the annual increase of overall endoscopic procedures performed in our unit.
Th e indications for PEG tube placement were malignancy in 44% (n=158), of which 61% (n=97) patients were suff ering from head and neck cancer and 39% (n=61) of other malignancy. Central nervous disease was the indication in 48.7 % (n=175) of patients. Cerebrovascular accidents (CVA) accounted for 20% (n=73), head injury for 16% (n=59) and cerebral palsy for 11% (n=38). 19 patients (5%) suff ered from a congenital anomaly, 7 (2%) from a motor neuron disease and 5 (1%) from dementia. (Figure 1 and 2) .
In 6.13% (n=22) of patients minor complications occurred aft er PEG tube insertion, which included wound infection (n=3, 0.8%), tube leakage (n=4, 1.10%), stoma leakage (n=2, 0.56%), inadvertent PEG removal (n=9, 2.5%) and tube blockage (n=4, 1.1%). 11 patients (3%) experienced major complications including hemorrhage (n=4, 1.1%), tube migration (n=3, 0.8%) and buried bumper syndrome (n=2, 0.56%). In one patient during PEG placement duodenal perforation occurred, which was resolved by endoscopic clipping. Th ere was one case of tumor seeding at the PEG stoma in a patient with pharyngeal adenocarcinoma. No patient developed neither peritonitis nor aspiration pneumonia aft er PEG placement. Th ere were no deaths related to PEG procedure placement. 57 (15.8%) patients died within 30 days due to primary disease. Oral feeding was resumed in 23% of the patients and the tube was removed subsequently aft er 6 -14 months (Table 1 ).
DISCUSSION
Although success rates greater than 95% have been reported for PEG, procedure-related complications are common. Complications related to PEG placement and feeding are traditionally stratifi ed as major and minor. In our retrospective analysis we noticed a success rate of 98% PEG tube placement, an overall complication rate of 9.2% and no procedure-related deaths. Th ese results are in line with a large meta-analysis, which reported a procedure-related morbidity of 9.4% and mortality of 0.53% (5, 6) .
In our analysis 22 patients experienced minor complications including 3 wound infections and no case of subcutaneous abscess or cellulitis. Th e wound infection rate in the literature ranges from 5-25% (7, 8, 9) . Antibiotic prophylaxis reduces the infection rate to about 3 % (10, 11). Currently, there is still a controversial debate in the literature as to whether a single administration of an antibiotic, as a general prophylaxis, provides eff ective protection against peristomal infection. Th e European Society of Parenteral and Enteral Nutrition recommend that, in experienced hands under established hygienic conditions, routine antibiotic prophylaxis is not mandatory for PEG placement (12) . Our results confi rm this recommendation as we noticed a very low infection rate of 0.8%, although our patients did not routinely receive periprocedural antibiotics. Only fi ve patients received a single dose of an antibiotic (2g of cephazolin i.v.) prior PEG insertion, all of them were highly immunocompromised.
We therefore concluded that technique-related factors, as small abdominal wall incision and low traction on the PEG tube, have a great impact on PEG site infections. Nevertheless, in immunocompromised patients (patient with diabetes mellitus, patients on immunomodulatory and corticosteroid medication) we highly recommend the use of a single dose of an antibiotic as general prophylaxis.
Blockage of the tube is a common problem seen in patients with longterm enteral nutrition via PEG. 16-31% of PEG tubes had at least 1 episode of signifi cant blockage during 18 months of follow-up, of which 7% required removal (13) . In our review only 4 (1.1%) patients showed an irreversible tube blockage that required tube exchange. We advise frequent water fl ushes (before and aft er feeding), administering liquid medication or well-ground pills to avoid feeding-tube blockage.
In our series we noticed two cases of buried bumper syndrome (BBS), which is an uncommon but serious complication of PEG, occurring in 1.5-1.9% of patients (14) . A variety of techniques have been used to manage the BBS (15, 16) . In our unit both cases were managed endoscopically, without further complications. We concluded the endoscopic approach of the BBS as a minimal invasive and safe method. Indication in 44% of our patient group was malignant disease, the majority of them (61%) suff ering from head and neck cancer. It has been clearly shown that PEG-feeding is eff ective in reducing weight loss, malnutrition and hospitalization in this patient group (17) . Current practice includes pre-treatment PEG placement in the management of patients undergoing chemoradiation [18] . However, even in those patients who get PEG in a later stage of disease and in those who remain dependent on enteral feeding PEG has been shown to contribute to improved quality of life (19) .
Th e high mortality rate of 15.8% within 30 days aft er PEG placement is more likely to be related to advanced primary diagnosis and poor general condition than to the procedure itself. Previous studies that involve a heterogeneous population report 30-day mortality rates ranging from 9-31% (20, 21) . Factors that predicting successful long-term outcome of PEG tube feeding have not been well studied, but it seems like co-morbidity aff ects patient's survival. Another study reported an overall mortality rate of 28% in patients aft er PEG placement, which increased to 54% in the subgroup of patients with dementia (22) . In our report just 1% of patients suff ered from dementia with no evidence of higher 30-day mortality rate and it seems that PEG placement in this patient group continuous to be a major area of controversy.
CONCLUSIONS
Our 7-year clinical experience showed that PEG placement is a save and minimally invasive endoscopic procedure associated with a procedure-related low morbidity (9.2%) rate, easy to follow-up and to replace when blockage occurs. PEG provides durable access for enteral nutrition, prevents malnutrition and reduces hospitalization in cancer patients. Over a seven-year period we noticed an increase of 63% in PEG placement at our department.
